Henry Schein Inc. to supply dog cancer diagnosis kits

The veterinary supply unit of Henry Schein Inc., of Melville, has a new agreement to distribute canine cancer diagnosis kits.

In the deal, Butler Schein Animal Health will buy the kits from the Canadian manufacturer, OncoPet Diagnosis Inc., then resell them to Schein's customer network of 26,000 U.S. veterinary clinics.

The companies did not disclose financial terms of the deal to distribute the OncoPet Sample Collection kits.

Henry Schein Inc., Long Island's largest publicly traded company, has 14,000 employees and a market capitalization of $5.67 billion. In the past four quarters it had $355.9 million profit on $8.21 billion sales.

OncoPet is a unit of the British Columbia firm BioCurex Inc.

"With the largest animal health distribution company in the U.S. now under agreement with OncoPet, we are confident that our products and services will be comprehensively represented to animal health professionals throughout the largest veterinary market in the world," Paul D. Slowey, president of BioCurex, said in a Thursday news release.

Schein's veterinary supply unit is based in Dublin, Ohio, where it employs about 900 including 300 field sales representatives and 200 telesales and customer support representatives. It has 17 distribution facilities and 12 inside sales centers nationwide.

Photo shows Stanley Bergman, chief executive of Henry Schein.